Results 151 to 160 of about 11,169 (205)

A single-centre, retrospective cohort study of paediatric tinea capitis in the United Kingdom. [PDF]

Skin Health Dis
Herd E, Gardner L, Leech S, Weiand D, Dubois A, Carson L.   +5 more
europepmc   +1 more source

Comparison of DermaGenius and In-House qPCR Methods for Detection of Recalcitrant Dermatophyte Infections: A Practical Approach for Dermatologists and Mycologists. [PDF]

Mycoses
Durdu M, Kaplan E, Bingöl O, Ünal N, Demircili ME, Spruijtenburg B, do Prado CM, Meijer EFJ, Ilkit M.   +8 more
europepmc   +1 more source

Evaluation of Liofilchem Derma-SR-Screen 4-Well Agar Panels in Screening of Terbinafine and Itraconazole Susceptibility in Clinical <i>Trichophyton</i> Isolates. [PDF]

J Fungi (Basel)
Jørgensen KM, Abou-Chakra N, Astvad KMT, Arendrup MC.   +3 more
europepmc   +1 more source

Fungal Skin Infections in Cutaneous T-cell Lymphoma Patients under Mogamulizumab Treatment. [PDF]

Acta Derm Venereol
Melchers S, Gerigk M, Hedke M, Weiß C, Nicolay JP.   +4 more
europepmc   +1 more source

From Dermographism in Bracelets to Dermatophytosis in Circles: The First Case of Tinea Imbricata Diagnosed in Morocco. [PDF]

Cureus
Mansar N, Naciri N, El Mezouari EM, Moutaj R.   +3 more
europepmc   +1 more source

Severe dysgeusia and weight loss associated with terbinafine use: A case report. [PDF]

J Family Med Prim Care
Cavendish JJ, Garan RM, Gibbs MM, Harris EM.   +3 more
europepmc   +1 more source

Terbinafine Resistance in Dermatophytes: A French Multicenter Prospective Study

Journal of Fungi (Basel, Switzerland), 2022
In recent years, we have moved from the sporadic description of terbinafine-resistant (TerR) Trichophyton spp. isolates to the Indian outbreak due to T. indotineae. Population flows have spread TerR worldwide, altering local epidemiology.
Sandrine Houzé, Eric Dannaoui, Françoise Botterel   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Terbinafine: An update

Journal of the American Academy of Dermatology, 1997
Oral terbinafine was first introduced in the United Kingdom in February 1991 and was approved for the treatment of onychomycosis in the United States in May 1996. It is estimated that 4 million patients worldwide have been treated with oral terbinafine as of December 1996.
A K, Gupta, N H, Shear
openaire   +2 more sources